{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:08Z","timestamp":1790713208135,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.prro.2018.10.009","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T22:02:26Z","timestamp":1541196146000},"page":"e164-e171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel"],"prefix":"10.1016","volume":"9","author":[{"given":"Margaret M.","family":"Kozak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"von Eyben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2018.10.009_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2014An update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.prro.2018.10.009_bib2","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2018.10.009_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0168-1702(02)00197-1","article-title":"Strategies for HPV prevention","volume":"89","author":"Plummer","year":"2002","journal-title":"Virus Res"},{"key":"10.1016\/j.prro.2018.10.009_bib4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2018.10.009_bib5","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.009_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2018.10.009_bib7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.009_bib8","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.1999.17.7.2055","article-title":"Chemoradiation and adjuvant chemotherapy in cervical cancer","volume":"17","author":"Wong","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.009_bib9","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.009_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijrobp.2016.11.027","article-title":"Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: An international multicenter phase II clinical trial (INTERTECC-2)","volume":"97","author":"Mell","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2009.06.041","article-title":"Clinical outcomes of definitive intensity modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer","volume":"77","author":"Kidd","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.10.075","article-title":"Consensus guidelines for delineation of clinical target volume for intensity modulated pelvic radiotherapy for the definitive treatment of cervix cancer","volume":"79","author":"Lim","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijrobp.2008.03.064","article-title":"Cervix regression and motion during the course of external beam chemoradiation for cervical cancer","volume":"73","author":"Beadle","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brachy.2012.01.004","article-title":"Counterpoint: Time to retire the parametrial boost","volume":"11","author":"Lindegaard","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2018.10.009_bib15","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0360-3016(00)00771-9","article-title":"Intensity modulated whole pelvic radiation therapy in patients with gynecologic malignancies","volume":"48","author":"Roeske","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2003.05.001","article-title":"A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity modulated whole-pelvic radiation therapy","volume":"69","author":"Roeske","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.10.009_bib17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0360-3016(03)00325-0","article-title":"Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity modulated whole pelvic radiation therapy","volume":"56","author":"Mundt","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","article-title":"Intensity modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation","volume":"51","author":"Portelance","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2015.01.037","article-title":"Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011","volume":"92","author":"Smith","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib20","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2016.06.024","article-title":"A phase III randomized trial comparing patient-reported toxicity and quality of life (QoL) during pelvic intensity modulated radiation therapy as compared to conventional radiation therapy","volume":"96","author":"Klopp","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ijrobp.2009.02.044","article-title":"Does the entire uterus need to be treated in cancer of the cervix? Role of adaptive brachytherapy","volume":"76","author":"Anker","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijrobp.2014.09.009","article-title":"More accurate definition of clinical target volume based on the measurement of microscopic extensions of the primary tumor toward the uterus body in international federation of gynecology and obstetrics Ib-IIa squamous cell carcinoma of the cervix","volume":"91","author":"Xie","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.009_bib23","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1200\/JCO.2006.07.4799","article-title":"Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651\/GOG 183 Intergroup Study","volume":"24","author":"Mitchell","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.009_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4329\/wjr.v8.i4.342","article-title":"Current imaging strategies for the evaluation of uterine cervical cancer","volume":"8","author":"Bourgioti","year":"2016","journal-title":"World J Radiol"},{"key":"10.1016\/j.prro.2018.10.009_bib25","doi-asserted-by":"crossref","first-page":"141211414","DOI":"10.1111\/IGC.0b013e3181b62e8c","article-title":"18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer","volume":"19","author":"Showalter","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2018.10.009_bib26","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018303102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018303102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:21:03Z","timestamp":1761819663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850018303102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1879850018303102"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2018.10.009","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2018.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}